高级检索
    马胜林, 殷靖宜. TKI 治疗有或无T790M突变的肺腺癌患者疗效的对照研究[J]. 循证医学, 2013, 13(1): 34-36. DOI: 10.3969/j.issn.1671-5144.2013.01.004
    引用本文: 马胜林, 殷靖宜. TKI 治疗有或无T790M突变的肺腺癌患者疗效的对照研究[J]. 循证医学, 2013, 13(1): 34-36. DOI: 10.3969/j.issn.1671-5144.2013.01.004
    shu
    MA Sheng-lin, YIN Jing-yi. Efficacy of TKI Therapy in Lung Adenocarcinoma Patients with or without T790M Mutation——A Control Study[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 34-36. DOI: 10.3969/j.issn.1671-5144.2013.01.004
    Citation: MA Sheng-lin, YIN Jing-yi. Efficacy of TKI Therapy in Lung Adenocarcinoma Patients with or without T790M Mutation——A Control Study[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 34-36. DOI: 10.3969/j.issn.1671-5144.2013.01.004
    shu

    TKI 治疗有或无T790M突变的肺腺癌患者疗效的对照研究

    Efficacy of TKI Therapy in Lung Adenocarcinoma Patients with or without T790M Mutation——A Control Study

      摘要
      • HTML全文
      • 参考文献(16)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回